Open AccessInsights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
Author(s) -
Zhu Jing,
Rao Gauri,
Armistead Paul M.,
Ptachcinski Jonathan,
Weiner Daniel L.,
Wiltshire Tim,
Crona Daniel J.
Publication year - 2022
Publication title -
clinical and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 44
eISSN - 1752-8062
pISSN - 1752-8054
DOI - 10.1111/cts.13177
Subject(s) - covid-19 , pandemic , hematopoietic stem cell transplantation , medicine , hematopoietic cell , stem cell , hematopoietic stem cell , medline , haematopoiesis , coronavirus infections , virology , intensive care medicine , immunology , transplantation , biology , genetics , disease , infectious disease (medical specialty) , outbreak , biochemistry